ÂÜÀòÂÒÂ×

Fred Colen currently serves as the Chairman of the Board at Xeltis AG and has extensive experience in leadership roles within the medical technology sector. Since 2017, Fred Colen has been a member of the Board of Directors at ONWARD and has held the position of President at MedTech Lighthouse since 2015. Previous roles include President and CEO of Neovasc Inc. from 2018 to 2023, and CEO and President of BeneChill from 2011 to 2016. Fred Colen has also contributed to various boards such as Molnlycke Health Care and Middle Peak Medical GmbH. An extensive background at Boston Scientific includes serving as President of the Cardiac Rhythm Management Group and Chief Technology Officer. Fred Colen's academic background includes a Master of Science in Electrical Engineering from RWTH Aachen University and a Bachelor's Degree in Electrical Engineering from the Technical University in Eindhoven.